Mutations in the anti-sigma H factor RshA confer resistance to econazole and clotrimazole in Mycobacterium smegmatis
Open Access
- 1 December 2019
- journal article
- Published by Microbiology Society in Access Microbiology
- Vol. 1 (10) , e000070
Abstract
Azole drugs such as econazole, are active on Mycobacterium tuberculosis and Mycobacterium smegmatis ; however, the identification of their target(s) is still pending. It has been reported that mutations in the non-essential system mmpL5-mmpS5 conferred resistance to econazole in M. tuberculosis . We herein report that an azole-resistant mutant screen in M. smegmatis rendered mutations in rshA, encoding a non-essential anti-sigma H protein.Keywords
This publication has 31 references indexed in Scilit:
- Function, essentiality, and expression of cytochrome P450 enzymes and their cognate redox partners in Mycobacterium tuberculosis: are they drug targets?Applied Microbiology and Biotechnology, 2019
- The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosisThe Lancet Respiratory Medicine, 2017
- Combating drug-resistant tuberculosis: the unexpected benefits of bedaquilineThe International Journal of Tuberculosis and Lung Disease, 2017
- The Mycobacterium tuberculosis cytochrome P450 systemArchives of Biochemistry and Biophysics, 2010
- Mycobacterial Cytochrome P450 125 (Cyp125) Catalyzes the Terminal Hydroxylation of C27 SteroidsJournal of Biological Chemistry, 2009
- The preponderance of P450s in the Mycobacterium tuberculosis genomeTrends in Microbiology, 2006
- In vitro and ex vivo antimycobacterial potential of azole drugs againstMycobacterium tuberculosisH37RvFEMS Microbiology Letters, 2005
- Altered expression profile of mycobacterial surface glycopeptidolipids following treatment with the antifungal azole inhibitors econazole and clotrimazoleMicrobiology, 2005
- The ergosterol biosynthesis pathway, transporter genes, and azole resistance inAspergillus fumigatusMedical Mycology, 2005
- Azole antifungals are potent inhibitors of cytochrome P450 mono-oxygenases and bacterial growth in mycobacteria and streptomycetesMicrobiology, 2002